Nomura Holdings Inc Abb Vie Inc. Call Options Transaction History

Nomura Holdings Inc

$50.5 Billion
Q2 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $417,933 - $488,052	2,700 Added 18.0%	17,700 $3.04 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $2.4 Million - $2.73 Million	15,000 New	15,000 $2.73 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $3.73 Million - $4.3 Million	25,800 Added 48.04%	79,500 $12.7 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $13.3 Million - $16 Million	-96,300 Reduced 64.2%	53,700 $8.68 Million
Q3 2022 Nov 15, 2022	SELL	$134.21 - $153.93 $13.4 Million - $15.4 Million	-100,000 Reduced 40.0%	150,000 $20.2 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $472 Million - $600 Million	-3,427,200 Reduced 93.2%	250,000 $38.4 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $354 Million - $448 Million	3,297,200 Added 867.68%	3,677,200 $498 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $37.2 Million - $42.3 Million	350,000 Added 1166.67%	380,000 $41.4 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $1.55 Million - $2.35 Million	-24,000 Reduced 44.44%	30,000 $2.29 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $1.88 Million - $2.35 Million	-26,000 Reduced 32.5%	54,000 $4.78 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $21 Million - $25.2 Million	-333,200 Reduced 80.64%	80,000 $5.86 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $10.6 Million - $14.2 Million	-115,000 Reduced 21.77%	413,200 $39.1 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $38 Million - $50.9 Million	413,200 Added 359.3%	528,200 $52.1 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $4.34 Million - $4.76 Million	48,500 Added 72.93%	115,000 $13 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $4.65 Million - $5.93 Million	66,500	66,500 $5.91 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account